Frédéric Paré

431 total citations
23 papers, 355 citations indexed

About

Frédéric Paré is a scholar working on Molecular Biology, Rheumatology and Pharmacology. According to data from OpenAlex, Frédéric Paré has authored 23 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Rheumatology and 5 papers in Pharmacology. Recurrent topics in Frédéric Paré's work include Osteoarthritis Treatment and Mechanisms (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Digestive system and related health (5 papers). Frédéric Paré is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Inflammatory mediators and NSAID effects (5 papers) and Digestive system and related health (5 papers). Frédéric Paré collaborates with scholars based in Canada, France and United Kingdom. Frédéric Paré's co-authors include Jean‐François Beaulieu, Fabrice Escaffit, Dominique Jean, Caroline Francoeur, François Boudreau, Yannick D. Benoit, Nùria Basora, Johanne Martel‐Pelletier, Rémy Gauthier and Jean‐Pierre Pelletier and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Annals of the Rheumatic Diseases.

In The Last Decade

Frédéric Paré

21 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frédéric Paré Canada 11 177 73 73 55 54 23 355
Taro Masaki Japan 12 192 1.1× 64 0.9× 27 0.4× 16 0.3× 27 0.5× 30 434
Ivan Kanchev Czechia 10 103 0.6× 62 0.8× 30 0.4× 15 0.3× 25 0.5× 14 326
Wenjing Zhang China 11 193 1.1× 64 0.9× 39 0.5× 12 0.2× 23 0.4× 28 390
Ruhong Cheng China 13 210 1.2× 22 0.3× 69 0.9× 78 1.4× 42 0.8× 42 521
Tomoyuki Oshio Japan 9 173 1.0× 48 0.7× 54 0.7× 64 1.2× 23 0.4× 13 436
Serpil DAĞ Türkiye 4 448 2.5× 147 2.0× 51 0.7× 41 0.7× 19 0.4× 46 641
Vivian Takafuji United States 7 122 0.7× 65 0.9× 70 1.0× 21 0.4× 103 1.9× 9 367
Aisuke Nii Japan 10 147 0.8× 64 0.9× 42 0.6× 10 0.2× 30 0.6× 27 377
David Obeso Spain 14 310 1.8× 31 0.4× 46 0.6× 104 1.9× 23 0.4× 27 569
Frank Dastvan United States 9 223 1.3× 36 0.5× 34 0.5× 26 0.5× 14 0.3× 9 418

Countries citing papers authored by Frédéric Paré

Since Specialization
Citations

This map shows the geographic impact of Frédéric Paré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Paré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Paré more than expected).

Fields of papers citing papers by Frédéric Paré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Paré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Paré. The network helps show where Frédéric Paré may publish in the future.

Co-authorship network of co-authors of Frédéric Paré

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Paré. A scholar is included among the top collaborators of Frédéric Paré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Paré. Frédéric Paré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Zhipeng, Frédéric Paré, Geneviève Lavoie, et al.. (2025). 14-3-3ζ allows for adipogenesis by modulating chromatin accessibility during the early stages of adipocyte differentiation. Molecular Metabolism. 97. 102159–102159.
2.
Mugabo, Yves, et al.. (2024). Plakoglobin regulates adipocyte differentiation independently of the Wnt/β-catenin signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(4). 119690–119690. 1 indexed citations
3.
Tardif, Ginette, Frédéric Paré, Clarisse Gotti, et al.. (2022). Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers. Arthritis Research & Therapy. 24(1). 120–120. 20 indexed citations
4.
Mugabo, Yves, Cheng Zhao, Anindya Ghosh, et al.. (2022). 14-3-3ζ Constrains insulin secretion by regulating mitochondrial function in pancreatic β cells. JCI Insight. 7(8). 17 indexed citations
5.
Najar, Mehdi, Frédéric Paré, Bertrand Lussier, et al.. (2021). L-PGDS deletion accelerates the development of aging-associated osteoarthritis. Osteoarthritis and Cartilage. 29. S95–S95. 1 indexed citations
6.
Najar, Mehdi, Frédéric Paré, Bertrand Lussier, et al.. (2020). Role of Lipocalin‐Type Prostaglandin D Synthase in Experimental Osteoarthritis. Arthritis & Rheumatology. 72(9). 1524–1533. 10 indexed citations
7.
Paré, Frédéric, et al.. (2020). In vivo protective effect of adipsin-deficiency on spontaneous knee osteoarthritis in aging mice. Aging. 12(3). 2880–2896. 13 indexed citations
8.
Tardif, Ginette, François Mineau, Frédéric Paré, et al.. (2018). High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models. Lara D. Veeken. 57(10). 1851–1860. 20 indexed citations
9.
Paré, Frédéric, et al.. (2017). In vivo effect of opticin deficiency in a surgically induced model of osteoarthritis. Osteoarthritis and Cartilage. 25. S61–S61. 1 indexed citations
10.
Paré, Frédéric, et al.. (2014). Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway. Experimental Cell Research. 322(2). 355–364. 33 indexed citations
12.
Benoit, Yannick D., Frédéric Paré, Caroline Francoeur, et al.. (2010). Cooperation between HNF-1α, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line. American Journal of Physiology-Gastrointestinal and Liver Physiology. 298(4). G504–G517. 60 indexed citations
13.
Dydensborg, Anders Bondo, Inga C. Teller, Jean‐François Groulx, et al.. (2009). Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity. BMC Cancer. 9(1). 223–223. 35 indexed citations
14.
Boileau, Christelle, Johanne Martel‐Pelletier, Judith Caron, et al.. (2009). Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2. Annals of the Rheumatic Diseases. 69(6). 1179–1184. 12 indexed citations
15.
Dydensborg, Anders Bondo, Inga C. Teller, Nùria Basora, et al.. (2008). Differential expression of the integrins α6Aβ4 and α6Bβ4 along the crypt–villus axis in the human small intestine. Histochemistry and Cell Biology. 131(4). 531–536. 30 indexed citations
16.
Fanello, Serge, et al.. (2008). Épidémiologie de la plainte allergique en médecine générale. Revue Française d Allergologie et d Immunologie Clinique. 48(7). 476–486. 2 indexed citations
17.
Escaffit, Fabrice, Frédéric Paré, Rémy Gauthier, et al.. (2006). Cdx2 modulates proliferation in normal human intestinal epithelial crypt cells. Biochemical and Biophysical Research Communications. 342(1). 66–72. 40 indexed citations
18.
Escaffit, Fabrice, Nathalie Perreault, Dominique Jean, et al.. (2004). Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance. Experimental Cell Research. 302(2). 206–220. 42 indexed citations
19.
Lussier, Carine, et al.. (2003). The RGD-dependent adhesion system in human intestinal epithelial cells: Involvement of multiple integrins and ligands. Gastroenterology. 124(4). A278–A278. 1 indexed citations
20.
Labeille, B., et al.. (1990). [Severe pseudotumoral panniculitis in the child: cytophagic histiocytic panniculitis? Favorable outcome with chemotherapy].. PubMed. 117(11). 807–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026